Pasture Holdings’ earnings rebound in FY 2024

The company has rebounded from a net loss of US$1.3m to a net profit of US$0.6m.

Pasture Holdings rebounded from a net loss of $1.7m (US$1.3m) to a net profit of $0.73m (US$0.6m) in FY 2024.

Revenue for the period surged 44.9% year-on-year (YoY) to $18.3m (US$14.0m), driven by a 43.7% YoY growth in its pharmaceutical business which recorded a revenue of $18.2m (US$13.9m) with new customer acquisitions and more orders from existing customers.

The mask and medical supplies business also grew 300% to $201,434 (US$154,000) from $58,860 (US$45,000) in FY 2023.

Meanwhile, gross profit more than doubled to $4.6m (US$3.5m) due to higher revenue and related operational efficiencies achieved.

Pasture Holdings maintains a positive outlook amidst favourable structural trends such as the ageing global population, an enlarged cold chain warehouse capacity, and potential growth in new non-core business

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia